Special Issue "Mesoporous Silica in Biomedical Applications"
Deadline for manuscript submissions: closed (10 December 2017)
Prof. Dr. Jessica Rosenholm
Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Åbo Akademi University, BioCity (3rd floor), Artillerigatan 6A, FI 20520 Turku, Finland
Website | E-Mail
Phone: + 358-2-215-3255
Interests: nanomedicine; drug delivery; biomaterials engineering; bioimaging probes; biomedical nanotechnology; pharmaceutical technology
Mesoporous silica has emerged at the forefront of promising carrier materials under development, owing to its characteristic properties, including tuneable pore size and structure, extensive surface area and pore volume, flexible surface functionalization, as well as controllable particle sizes and shapes on the nanoscale. The advent of such mesoporous silica nanoparticles (MSNs) resulted in a boom of developments within intracellular drug delivery, highlighted by a multitude of successful proof-of-concept studies, especially within targeted cancer therapies. The vast applicability of these materials as delivery vehicles for virtually any active molecule of choice, including small-molecular drugs, peptides, proteins, nucleic acids, as well as imaging agents and sensing molecules, together with their modularity in design approaches, to date, has showcased some highly sophisticated systems. The mesoporous silica synthesis regime further allows for the construction of core–shell nanocomposites, which can further expand the multimodality of the final particle construct, since the core material can also be chosen, practically at will. With the first-in-man study published in 2016, this Special Issue aims to provide a forum for the dissemination of the latest developments and new approaches for the design, utilization, and evaluation of mesoporous silica in biomedicine.
Prof. Dr. Jessica Rosenholm
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Mesoporous silica nanoparticles (MSNs)
- Drug delivery systems
- Cancer treatment and diagnostics
- Intracellular drug delivery
- Targeted drug delivery
- Stimuli-responsive drug release
- Biomedical imaging and contrast agents
- Photodynamic therapy
- Nucleic acid delivery and gene therapy
- Core-shell particles
- Formulation design